CLASS II Device recall · Reported 17 Dec 2014 · FDA Enforcement Report

Inomax Dsir Nitric Oxide delivery system recalled by INO Therapeutics (

INO Therapeutics ( is recalling Inomax Dsir Nitric Oxide delivery system, distributed in Pennsylvania, Virginia. The recall was initiated on 17 Oct 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSerial Numbers: DS20080152, DS20090925, DS20101076, DS20101499, DS20110886, DS20110965, DS20120099, DS20120150, DS20120169.
Quantity recalled9

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0575-2015
FDA event ID
69635
Recalling firm
INO Therapeutics (, Madison, WI
Classification
Class II
Status
Terminated
Recall initiated
17 Oct 2014
FDA classified
9 Dec 2014
Reported
17 Dec 2014
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Device Malfunction
Device type
Patient Monitors

Timeline

17 Oct 2014Recall initiated by company
9 Dec 2014Classified by FDA+53 days
17 Dec 2014Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

An issue has been identified in the INOmax DSIR system that could result in monitored Nitric Oxide (NO) concentration reporting lower than expected. This issue only pertains to those devices manufactured using a specific version of the Monitoring Circuit Board.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

INOMAX DSIR Nitric Oxide delivery system, Model 10007, software version 3.1.0., delivers INOMAX (nitric oxide for inhalation) therapy gas and provides continuous monitoring of inspired O2, NO2, and NO, and comprehensive alarm systems. The primary clinical settings are Neonatal Intensive Care Units (NICU) and to transport of neonates.

Where it was distributed

US Distribution in states of: VA and PA only.

PennsylvaniaVirginia

Questions about this recall

Why was it recalled?

An issue has been identified in the INOmax DSIR system that could result in monitored Nitric Oxide (NO) concentration reporting lower than expected. This issue only pertains to those devices manufactured using a specific version of the Monitoring Circuit Board.

Which lots are affected?

Serial Numbers: DS20080152, DS20090925, DS20101076, DS20101499, DS20110886, DS20110965, DS20120099, DS20120150, DS20120169.

Where was it sold?

US Distribution in states of: VA and PA only.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from INO Therapeutics (

All 4

Other Patient Monitors recalls

All 1,013